Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Short term Debt (2016 - 2025)

Historic Short term Debt for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $923000.0.

  • Amphastar Pharmaceuticals' Short term Debt rose 26626.98% to $923000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $923000.0, marking a year-over-year increase of 26626.98%. This contributed to the annual value of $234000.0 for FY2024, which is 4633.03% down from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Short term Debt is $923000.0, which was up 26626.98% from $927000.0 recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Short term Debt peaked at $12.9 million during Q2 2023, and registered a low of $224000.0 during Q1 2025.
  • For the 5-year period, Amphastar Pharmaceuticals' Short term Debt averaged around $2.8 million, with its median value being $1.7 million (2022).
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Short term Debt skyrocketed by 52809.92% in 2023, and later tumbled by 9807.28% in 2024.
  • Amphastar Pharmaceuticals' Short term Debt (Quarter) stood at $2.2 million in 2021, then soared by 38.33% to $3.0 million in 2022, then crashed by 85.69% to $436000.0 in 2023, then tumbled by 46.33% to $234000.0 in 2024, then surged by 294.44% to $923000.0 in 2025.
  • Its last three reported values are $923000.0 in Q3 2025, $927000.0 for Q2 2025, and $224000.0 during Q1 2025.